May 3, 2021
Published by admin on May 3, 2021
Categories
Oculus Biomed Limited (“OBM”) is pleased to announce the application of the Chinese Patent which covers its OBM-1701 has been allowed. The term of the Chinese […]
January 8, 2021
Published by admin on January 8, 2021
Categories
Oculus Biomed Limited (“OBM”) is pleased to announce the grant of the Chinese Patent which covers its OBM- 17xx. The term of the Chinese patent extend […]
July 1, 2020
Published by admin on July 1, 2020
Categories
Oculus Biomed Limited (“OBM”) is pleased to announce that it has entered an Agreement with Mackay Memorial Hospital (“MMH”), in Taipei, Taiwan. Established on 26 December […]
May 15, 2020
Published by admin on May 15, 2020
Categories
Oculus Biomed Limited (“OBM”) announces that it had requested to terminate the acquisition discussion with Lanka Graphite Limited (“LGR”) (ASX:LGR), effective immediately. OBM has no further […]
February 18, 2020
Published by admin on February 18, 2020
Categories
Oculus Biomed Limited (“OBM”) is pleased to announce that it has entered into a non-binding Heads of Agreement (“HOA”) with Lanka Graphite Limited (“LGR”) (ASX: LGR). […]
November 5, 2019
Published by admin on November 5, 2019
Categories
Oculus Biomed Limited (“OBM”) is pleased to announce the grant of the USA Patent which covers its OBM-1701. The term of the Chinese patent extend its […]
August 31, 2018
Published by admin on August 31, 2018
Categories
Oculus Biomed Limited (“OBM”) is pleased to announce a batch of OBM-1701 has been successfully manufactured with the purity of 99.5% (as determined by the HPLC) […]